Clinical Trials Sponsored by L.E.A.D
Total 2 results
-
Revival ActiveAarogyam UK; L.E.A.DCompleted
-
Revival ActiveNMP Medical Research Institute; L.E.A.DCompleted
Sponsors and Collaborators
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Xiao-Ming Mao
- Liming Cheng
- Van Boven, Robert W., M.D.
- Kerstyn C. Zalesin, M.D.
- Hopeful Aging
- Genuv Inc.
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Pancreatic Cancer UK
- The People's Hospital of Guangxi Zhang Autonomous Region
- Klinikum Bad Woerishofen
- Marcus Vinícius Guimarães de Lacerda
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Kuwait University
- Royal Hobart Hospital Research Foundation (funding source)
- Egyptian Russian University
- Only For Children Pharmaceuticals
- Sahar Salehi
- Hoersholm Hospital
- Jia Liu
- View Full List
Medical Conditions
- Role of Vitamin D in IVF for Better Outcome
- Caffeine Dosage
- EHMT1
- Urinary Tract Carcinoma
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Airway Obstruction
- Advanced Gastric Cancer With Serosal Invasion
- Secondary Hypertension to Endocrine Disorders
- Stereotype-threat
- Raynaud Secondary to Other Autoimmune Disease
- Gait Variability; Elders; Fall; Re-education
- Stage II Vulvar Cancer
- Enlarged Uterus
- Autologous Haematopoietic Stem Cell Transplant
- Smith-Lemli-Opitz Syndrome
- Pancytopenia Due to Chemotherapy
- High Perinatal Mortality
- Pulmonary Invasive Aspergillosis
- Global Health
- View Full List
Drug Interventions
- Enzalutamide, Abiraterone
- SERETIDE Diskus
- Flibanserin 100 mg dose every evening
- Lamivudine
- Epimedium Prenylflavonoids Extract
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Methotrexate
- Mupirocin Calcium
- Oxycodone, fentanyl
- Insulin
- Bortezomib/dexamethasone
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Cytarabine ARA-C
- Topotecan
- Polyethylene glycol 3350
- Atezolizumab
- PF-00868554
- Ruxolitinib
- Indoximod
- Cetrorelix 78 mg + 78 mg
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Djibouti
- Contract Research Organizations in France
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kenya
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Panama
- Contract Research Organizations in Vietnam
- CRO list by country